Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Aptinyx Pulls Back From Neuropsychiatry After Mid-Stage PD Failure
Prioritizes Cutting Costs
Mar 01 2023
•
By
Ayisha Sharma
The Parkinson's Failure Is The Fourth Clinical Setback In Recent Years • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D